Jean Carruthers1, Alastair Carruthers, Shannon Humphrey. 1. Vancouver, British Columbia, Canada From the Department of Ophthalmology and Visual Sciences, University of British Columbia; and Department of Dermatology and Skin Science, University of British Columbia.
Abstract
BACKGROUND: Over the last few years, injectable soft-tissue fillers have become an integral part of cosmetic therapy, with a wide array of products designed to fill lines and folds and revolumize the face. METHODS: This review describes cosmetic fillers currently approved by the Food and Drug Administration and discusses new agents under investigation for use in the United States. RESULTS: Because of product refinements over the last few years-greater ease of use and longevity, the flexibility of multiple formulations within one line of products, and the ability to reverse poor clinical outcomes-practitioners have gravitated toward the use of biodegradable agents that stimulate neocollagenesis for sustained aesthetic improvements lasting up to a year or more with minimal side effects. Permanent implants provide long-lasting results but are associated with greater potential risk of complications and require the skilled hand of the experienced injector. CONCLUSIONS: A variety of biodegradable and nonbiodegradable filling agents are available or under investigation in the United States. Choice of product depends on injector preference and the area to be filled. Although permanent agents offer significant clinical benefits, modern biodegradable fillers are durable and often reversible in the event of adverse effects.
BACKGROUND: Over the last few years, injectable soft-tissue fillers have become an integral part of cosmetic therapy, with a wide array of products designed to fill lines and folds and revolumize the face. METHODS: This review describes cosmetic fillers currently approved by the Food and Drug Administration and discusses new agents under investigation for use in the United States. RESULTS: Because of product refinements over the last few years-greater ease of use and longevity, the flexibility of multiple formulations within one line of products, and the ability to reverse poor clinical outcomes-practitioners have gravitated toward the use of biodegradable agents that stimulate neocollagenesis for sustained aesthetic improvements lasting up to a year or more with minimal side effects. Permanent implants provide long-lasting results but are associated with greater potential risk of complications and require the skilled hand of the experienced injector. CONCLUSIONS: A variety of biodegradable and nonbiodegradable filling agents are available or under investigation in the United States. Choice of product depends on injector preference and the area to be filled. Although permanent agents offer significant clinical benefits, modern biodegradable fillers are durable and often reversible in the event of adverse effects.
Authors: Liying Cheng; Kai Ji; Ting-Yu Shih; Anthony Haddad; Giorgio Giatsidis; David J Mooney; Dennis P Orgill; Christoph S Nabzdyk Journal: Tissue Eng Part A Date: 2017-01-02 Impact factor: 3.845
Authors: Adele Sparavigna; Beatrice Tenconi; Andrea Maria Giori; Gilberto Bellia; Laura La Penna Journal: Clin Cosmet Investig Dermatol Date: 2019-01-17